SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-003479
Filing Date
2021-08-12
Accepted
2021-08-12 17:10:24
Documents
14
Period of Report
2021-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K phio_i8k.htm   iXBRL 8-K 29116
2 PRESS RELEASE phio_ex9901.htm EX-99.1 46801
3 GRAPHIC image_001.jpg GRAPHIC 2282
  Complete submission text file 0001683168-21-003479.txt   259444

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE phio-20210812.xsd EX-101.SCH 3030
5 XBRL LABEL FILE phio-20210812_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE phio-20210812_pre.xml EX-101.PRE 22362
7 EXTRACTED XBRL INSTANCE DOCUMENT phio_i8k_htm.xml XML 3602
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
Phio Pharmaceuticals Corp. (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36304 | Film No.: 211168645
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences